Daiichi-Sankyo (South Korea)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi-Sankyo (South Korea), South Korea, covering academic research published from 2007 to 2023. Read More.
Open Access Percentage
86%
Total
Publications
343
Total Open
Publications
294
Total
Citations
20K
Open Access
Percentage
86%
Total
Publications
343
Total Open
Publications
294
Total
Citations
20K
Breakdown
Publisher Open
44%
Both
28%
Other Platform Open
14%
Closed
14%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 11%
28
Hybrid 27%
66
No Guarantees 62%
153
Other Platform Open
Domain 79%
114
Institution 35%
51
Preprint 10%
14
Other Internet 10%
14
Public 6%
8
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 113 |
Europe PMC | Domain | 61 |
Research Square | Preprint | 13 |
DOI | Other Internet | 12 |
University of Birmingham - University of Birmingham Research Portal | Institution | 9 |
Semantic Scholar | Public | 8 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 6 |
University of California - eScholarship University of California | Institution | 5 |
KU Leuven - Lirias | Institution | 5 |
California Digital Library - eScholarship | Other Internet | 5 |